Stopping progression to tophaceous gout. When and how to use urate-lowering therapy.
Although the prevalence of tophaceous gout has decreased in the past few years, the disease still exists, and without accurate diagnosis and therapy, it can still result in destructive arthritis. However, use of urate-lowering drugs may reduce plasma urate concentrations enough to allow resorption of tophi and prevent painful tophaceous gout. Some patients may have mechanical problems from tophi, despite adequate control of acute arthritis; in such situations, joint replacement or surgical excision of tophi may be necessary.
McDonald
E
E
Department of Medicine, North Shore University Hospital, Forest Hills, New York 11375, USA.
Marino
C
C
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000493:Allopurinol / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D015210:Arthritis, Gouty / Q000188:drug therapy; D003078:Colchicine / Q000008:administration & dosage; D003937:Diagnosis, Differential; D005260:Female; D006073:Gout / Q000175:diagnosis / Q000188:drug therapy*; D006074:Gout Suppressants / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D014528:Uricosuric Agents / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D014528:Uricosuric Agents; D000493:Allopurinol; D003078:Colchicine